Cotinine-verified 7-day point prevalence abstinence at week 26 by race, age, and sex cohorts with missing imputed as smokers*
Age, y . | Black, No. (%) . | White, No. (%) . | ||
---|---|---|---|---|
Male . | Female . | Male . | Female . | |
<40 | 4/56 (7.1) | 5/56 (8.9) | 17/57 (29.8) | 9/56 (16.1) |
≥40 | 9/56 (16.1) | 14/56 (25.0) | 16/56 (28.6) | 13/56 (23.2) |
Age, y . | Black, No. (%) . | White, No. (%) . | ||
---|---|---|---|---|
Male . | Female . | Male . | Female . | |
<40 | 4/56 (7.1) | 5/56 (8.9) | 17/57 (29.8) | 9/56 (16.1) |
≥40 | 9/56 (16.1) | 14/56 (25.0) | 16/56 (28.6) | 13/56 (23.2) |
*Slash marks indicate fraction.
Cotinine-verified 7-day point prevalence abstinence at week 26 by race, age, and sex cohorts with missing imputed as smokers*
Age, y . | Black, No. (%) . | White, No. (%) . | ||
---|---|---|---|---|
Male . | Female . | Male . | Female . | |
<40 | 4/56 (7.1) | 5/56 (8.9) | 17/57 (29.8) | 9/56 (16.1) |
≥40 | 9/56 (16.1) | 14/56 (25.0) | 16/56 (28.6) | 13/56 (23.2) |
Age, y . | Black, No. (%) . | White, No. (%) . | ||
---|---|---|---|---|
Male . | Female . | Male . | Female . | |
<40 | 4/56 (7.1) | 5/56 (8.9) | 17/57 (29.8) | 9/56 (16.1) |
≥40 | 9/56 (16.1) | 14/56 (25.0) | 16/56 (28.6) | 13/56 (23.2) |
*Slash marks indicate fraction.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.